Boston, Massachusetts 2021-09-21 10:12:08 –
Editor’s Note: The live stream of the conversation is embedded below 1:00 pm Eastern Standard Time.
EVery weekly, STAT + subscribers have access to exclusive conversations with biotechnology, pharmaceutical, and health tech leaders. This week, STAT’s General Assignment Reporter and Associate Editorial Director of the Event, Nicholas St. Fleur, will sit with Fabrice Chouraqui, CEO of Cellarity and CEO Partner of Flagship Pioneering. They asked how the new flagship company Cellarity recently raised $ 123 million to invent a drug by understanding the cellular network, what’s the next step, and of course your question. Will be discussed alive.
STAT+ Conversation: Selling Cellarity – STAT Source link STAT+ Conversation: Selling Cellarity – STAT